PROJECT OVERVIEW 

585 Kendall, located in the heart of Kendall Square, blends Cambridge’s historic role as an epicenter for the life science industry with the Canal District’s reputation as a vibrant hub for arts and recreation. The building, which will be home to Takeda Pharmaceutical Company’s newest facility in the area, also features a state-of-the-art community theater, creating a unique mix of scientific innovation and cultural engagement. 

SCOPE DESCRIPTION 

ICO provided a comprehensive scope of services spanning the entire project lifecycle, from early design through post-occupancy. ICO supported LEED commissioning efforts, performed special inspections and firestop inspections during construction, led Life Safety Integrative Testing, and verified building metering systems. Through continuous involvement from design review to post-occupancy verification, ICO maintained a strong presence on the project to ensure building systems were installed, tested, and operated in accordance with design intent and Owner requirements.